Gerresheimer has agreed to sell its Centor business and global Primary Packaging Plastics business to an affiliate of funds advised by Apax Partners. The two units have a combined enterprise value of €1.5bn, equivalent to $1.7bn. The sale covers the Centor site in the US and 15 manufacturing locations for primary plastic packaging across nine countries, which together posted combined revenue of roughly €570m in 2025 and employed 2,400 people. Gerresheimer expects the Centor transaction to close by the end of financial year 2026 and the Primary Packaging Plastics sale in the first half of financial year 2027. The company said the proceeds will be used to reduce leverage and optimise its capital structure, while sharpening its focus on high-value drug delivery systems, medical devices, and primary packaging for injectable drugs.
Gerresheimer AGGerresheimer sells two units for €1.5bn, using proceeds to reduce leverage and sharpen focus on high-value drug delivery systems.
Apax Funds acquire two packaging units with €1.5bn enterprise value, expanding their portfolio.